Zydus Lifesciences Ltd (BOM:532321)
₹ 964.4 -8.55 (-0.88%) Market Cap: 970.41 Bil Enterprise Value: 965.67 Bil PE Ratio: 22.61 PB Ratio: 4.45 GF Score: 97/100

Q3 2022 Cadila Healthcare Ltd Earnings Call Transcript

Feb 03, 2022 / 11:00AM GMT
Release Date Price: ₹407.6 (-1.66%)
Operator

Ladies and gentlemen, good day, and welcome to Cadila Healthcare Limited Q3 FY '22 Post Results Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Ganesh Nayak Executive Director at Cadila Healthcare Limited. Thank you, and over to you, sir.

Ganesh Narayan Nayak
Cadila Healthcare Limited - COO & Executive Director

Thank you. Good evening, ladies and gentlemen. Welcome to our post results teleconference for the quarter ended December 31, 2021. I do wish that you and your families are keeping safe and well. For today's call, we have with us Dr. Sharvil Patel, Managing Director; Mr. Nitin Parekh, Chief Financial Officer; Mr. Vishal Gor, Senior Vice President, Corporate Finance; and Alok Garg, Senior Vice President from the Managing Directors' Office.

I'm sure you would have gone through the quarterly results investors' presentation, which we have posted on our website and filed with the stock exchanges. The quarter gone by was yet another quarter of robust

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot